CSIMarket
 
Cytek Biosciences Inc   (CTKB)
Other Ticker:  
 
 
Price: $6.9500 $0.13 1.906%
Day's High: $7.01 Week Perf: -3.74 %
Day's Low: $ 6.68 30 Day Perf: -17.75 %
Volume (M): 1,333 52 Wk High: $ 12.31
Volume (M$): $ 9,264 52 Wk Avg: $7.88
Open: $6.73 52 Wk Low: $3.80



 Market Capitalization (Millions $) 938
 Shares Outstanding (Millions) 135
 Employees 300
 Revenues (TTM) (Millions $) 192
 Net Income (TTM) (Millions $) -12
 Cash Flow (TTM) (Millions $) -132
 Capital Exp. (TTM) (Millions $) 5

Cytek Biosciences Inc
Cytek Biosciences Inc is a leading life science company specializing in the development and manufacture of innovative flow cytometry solutions.
They provide a range of products and services for research, clinical and industrial applications.
Founded in 2011, the company is headquartered in Fremont, California, with additional offices in South Korea and China.
Cytek Biosciences has developed a unique flow cytometer platform called Aurora, which is designed to enable high-resolution analysis of up to 50 parameters in a single cell.
This system is particularly well-suited for applications such as immune monitoring, cell therapy, drug discovery, and cancer research.
The Aurora flow cytometer is also capable of analyzing rare cell populations, including circulating tumor cells and stem cells.
In addition to their cutting-edge technology, Cytek Biosciences offers a range of services to support their customers, including assay development, data analysis, and technical support.
Their expert team of scientists and engineers collaborate with researchers and clinicians around the world to develop customized solutions that meet their specific needs.
Cytek Biosciences is committed to advancing scientific research through their innovative technology and collaborative approach.
With their state-of-the-art flow cytometry solutions, they are helping to drive breakthroughs in fields such as cancer immunotherapy, regenerative medicine, and infectious disease research.


   Company Address: 47215 Lakeview Blvd. Fremont 94538 CA
   Company Phone Number: 922-9835   Stock Exchange / Ticker: NASDAQ CTKB
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Cytek Biosciences Inc

Cytek Biosciences Inc. Surges in Revenue, Defying Market Trends

CTKB, the leading cell analysis solutions company, has reported strong financial results for the fourth quarter and fiscal year 2023. The company showcased impressive growth, with income per share rising by 101.19% year on year to $0.04 per share and revenue increasing by 22.058% to $59.00 million.
This growth is particularly noteworthy considering the downward trend in the Laboratory Analytical Instruments sector. CTKB has defied industry peers, who experienced a decline in top-line revenue during the same period. Additionally, when compared sequentially, CTKB demonstrated positive progress, with income per share improving from $-0.05 per share and revenue increasing by 25.054% from $47.18 million.

Product Service News

Cytek Biosciences Expands Operations in China to Cater to Rising Global Demand for Advanced Cell Analysis Solutions

Published Thu, Mar 7 2024 10:30 PM UTC

Cytek Biosciences, a leading provider of innovative cell analysis solutions, has recently inaugurated a state-of-the-art 50,000-square-foot facility in Wuxi, China. This expansion aims to meet the escalating demand for cutting-edge cell analysis technology worldwide. With its increased manufacturing and research capabilities, Cytek Biosciences is poised to make significant c...

Contract

Cytek Biosciences Records Impressive Revenue Growth as It Teams Up with CRG and UPF to Accelerate Biomedical Discoveries

Published Wed, Jan 17 2024 10:30 PM UTC

In a pivotal move for increasing the rate of scientific discoveries, Cytek Biosciences, the leading biotechnology company, has recently announced a promising alliance with the Centre for Genomic Regulation (CRG) and The Pompeu Fabra University (UPF). The strategic agreement fosters a commitment towards bolstering advancements in the world of biosciences and highlights the on...

Management Announcement

Cytek Biosciences: Pioneering Cell Analysis Solutions, Outperforming Expectations

Published Mon, Jan 8 2024 2:01 PM UTC



In exciting news for the biotechnology industry, Cytek Biosciences, a renowned player in cell analysis solutions, has recently unveiled their preliminary full-year revenue results. With a commitment to innovation and cutting-edge technology, Cytek Biosciences has impressed investors and analysts alike, showcasing robust growth in an ever-evolving market. This artic...

Product Service News

Cytek's Orion Cocktail Prep System: Another Innovative Leap Amidst Soaring Profits

Published Thu, Dec 21 2023 2:00 PM UTC

Cytek Biosciences Inc., a trailblazer in the science industry, has pioneered a breakthrough with the introduction of the Cytek Orion Reagent Cocktail Preparation System. This novel creation, a first-of-its-kind automated cocktail preparation instrument for flow cytometry, promises to redefine the laboratory workflow by providing it with efficiency, consistency, and valuable ...






 

Cytek Biosciences Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Cytek Biosciences Inc does not provide revenue guidance.

Earnings Outlook
Cytek Biosciences Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com